NASDAQ · LMDXW
LumiraDx Limited
Healthcare · Medical - Diagnostics & Research
$0.00
Up+$0.00 (+0.00%)
Updated Sep 18, 2026, 2:21 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 5.1M
- P/E ratio
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 325.94K
- Avg. volume
- 325.94K
Price performance
LMDXW price history
1M range · 0 trading sessions · Daily adjusted prices
LMDXW does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest LMDXW news
The latest Smart Investors Daily articles mentioning LMDXW.
Stock researchCompany · Overview
LMDXW research
Overview
Company profile and research snapshot.
Company profile
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
